HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Cosmetics management

This article was originally published in The Rose Sheet

Executive Summary

Laura Klauberg appointed senior VP Marketing of Unilever Cosmetics International, overseeing marketing initiatives for company's three designer prestige fragrance divisions: Calvin Klein Cosmetics, Unilever Prestige and European Designer Parfums. Klauberg, a 20-year veteran of Unilever who most recently worked as skin care brand development VP in North America, will succeed three global marketing heads - Unilever Prestige President Laura Lee Miller, Calvin Klein President Hilary Dart and European Designer Parfums President Gabrielle Pungerscheg, who have left the company. New structure will unite the global marketing efforts for all three divisions under one head and create a more focused program, Unilever says. Klauberg will report directly to UCI President and CEO Kevin Boyce...

You may also be interested in...



Calvin Klein Signs Actress Johansson As Face Of New Women’s Fragrance

Calvin Klein Cosmetics has signed actress Scarlett Johansson as the face of a new fragrance positioned to appeal to younger women, the Unilever Cosmetics International division announced Feb. 17

Unilever Cosmetics International Innovation Revival Underway

Unilever Cosmetics International is stepping up innovation under new management to boost sales of the prestige fragrance unit, VP-Investor Relations Howard Green said during an Oct. 29 Q3 sales and earnings call

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel